We have located links that may give you full text access.
Journal Article
Review
New approaches to monitoring heart failure before symptoms appear.
Intrathoracic impedance monitoring (approved by the US Food and Drug Administration) and implantable hemodynamic monitoring (IHM), which is under investigation, are promising techniques for the improved management of heart failure by detecting early changes in fluid status or hemodynamic congestion. Routine outpatient surveillance of intrathoracic impedance data from implanted devices may significantly reduce the currently high rates of hospital admission/readmission for patients with heart failure. IHM systems may extend such monitoring capabilities. Both emerging approaches for monitoring patients with heart failure may alert clinicians (and possibly patients) to impending decompensation before symptoms appear.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app